ASSERTIO
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the manage... ment of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.
ASSERTIO
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Pharmaceutical
Founded:
1995-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.assertiotx.com
Total Employee:
101+
Status:
Active
Contact:
224.419.7106
Email Addresses:
[email protected]
Total Funding:
1.01 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Font API Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network
Similar Organizations
Agilent Technologies
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Alixia
Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Peplin
Peplin is a specialty pharmaceutical company focused on advancing and commercializing medical dermatology products.
Sumitomo Pharma America Holdings
Sumitomo Pharma America Holdings supports and enables the discovery, development, and commercialization of treatments to help patients.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-04-25 | Spectrum Pharmaceuticals | Spectrum Pharmaceuticals acquired by Assertio | N/A |
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Assertio
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Assertio
Morgan Stanley
Morgan Stanley investment in Post-IPO Debt - Assertio
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Debt - Assertio
Thomas Weisel Partners
Thomas Weisel Partners investment in Post-IPO Equity - Assertio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-01-17 | LGS Foundation | Assertio investment in Grant - LGS Foundation | 100 K USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-29 | Assertio names Brendan O’Grady as its new CEO |
| 2023-03-06 | Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical |
Official Site Inspections
http://www.assertiotx.com Semrush global rank: 2.94 M Semrush visits lastest month: 5.4 K
Unable to get host informations!!!
More informations about "Assertio"
Assertio Holdings » Management
Mr. Schwichtenberg previously served as Senior Vice President, Chief Financial Officer of Assertio since March 2021. Mr. Schwichtenberg joined Assertio as Vice President, Finance in …See details»
Assertio Holdings » Overview
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings, Inc. - Governance - Governance Documents
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio - Overview, News & Similar companies | ZoomInfo.com
Explore Complete Organization Structure. Is Assertio your ideal customer? Let us give you the heads up on whether it's a good time to reach out. Last 7 days. ... IL 60045 …See details»
Assertio Announces Restructuring Plan and Leadership Changes
Dec 15, 2020 To learn more about Assertio, visit www.assertiotx.com.Investor Contact Lee Roth Burns McClellan for Assertio Holdings, Inc. [email protected] [email protected] …See details»
Assertio Holdings, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 To learn more about Assertio, visit www.assertiotx.com. Investor Contact Matt Kreps, Managing DirectorDarrow AssociatesM: [email protected] . 02 Sep …See details»
Assertio - Overview, News & Similar companies | ZoomInfo.com
May 8, 2024 Assertio contact info: Phone number: (224) 419-7106 Website: www.assertiotx.com What does Assertio do? Founded in 1995, Assertio Therapeutics provides responsible …See details»
Assertio Holdings » Compliance & Ethics
The purpose of the CCP is to prevent, detect, and remediate violations of law, regulations, or Assertio policies, and to promote a culture of the highest ethics within the organization. The …See details»
Assertio Holdings, Inc. (ASRT) Company Profile & Overview - Stock …
Nov 5, 1997 Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an …See details»
Assertio Holdings, Inc. - Investor Relations
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Company Profile | Management and Employees List
SQL International Organization for Standardization . CSS World Wide Web Consortium . Network Hardware (4 Technologies) Cisco Nexus Cisco . Cisco Hardware Cisco . ...See details»
Assertio Holdings, Inc. - Events & Presentations
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio CEO and Key Executive Team | Craft.co
Assertio's President, Chief Executive Officer, Director is Dan A Peisert. Other executives include Jeff Christensen, Senior Vice President, Commercial; Sam Schlessinger, Vice President, …See details»
Assertio Company Profile - Office Locations, Competitors, Revenue ...
Oct 29, 2024 Assertio has 5 employees at their 1 location and $152.07 m in annual revenue in FY 2023. See insights on Assertio including office locations, competitors, revenue, financials, …See details»
Assertio Holdings » Assertio’s Action Plan
For our company, these truly are exciting times, however the start of our organization comes at a time of incredible turmoil in our country. While we’ve been navigating the impact of Covid-19 …See details»
Assertio Holdings, Inc. Announces Favorable Vote on Proposed
Jul 27, 2023 To learn more about Assertio, visit www.assertiotx.com. About Spectrum Spectrum is a commercial stage biopharmaceutical company, with a strategy of acquiring, developing, …See details»
Assertio Holdings » CORPORATE RESPONSIBILITY STATEMENT
Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001See details»
Assertio Holdings, Inc. - Financials - Annual Reports
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Assertio Holdings, Inc. - Assertio Holdings Third Quarter 2024 …
Nov 11, 2024 [email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After …See details»